What is the next step in managing an elderly male with severe Acute Respiratory Distress Syndrome (ARDS) and bilateral pneumonia, who is intubated and on ventilator support with polymyxin B (Polymyxin B), meropenem (Meropenem), and levofloxacin (Levofloxacin), and inotropes, following a sudden deterioration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Management of Sudden Deterioration in Severe ARDS

Immediately perform bedside echocardiography to assess for acute cor pulmonale (right ventricular failure), which occurs in 20-25% of severe ARDS patients and is the most likely cause of sudden deterioration in this clinical scenario. 1

Systematic Approach to Sudden Deterioration

1. Assess for Right Ventricular Failure (Most Critical)

Right ventricular dysfunction is independently associated with poor prognosis and requires immediate recognition. 1

  • Perform urgent echocardiography to evaluate RV size, function, and septal motion 1
  • Check for four key risk factors present in this patient: pneumonia as ARDS cause, PaO2/FiO2 <150 mmHg, driving pressure ≥18 cmH2O, and PaCO2 ≥48 mmHg 1
  • When all four factors are present, RV failure risk exceeds 60% 1

2. Optimize Ventilator Settings to Unload the Right Ventricle

Immediately adjust ventilator parameters as respiratory strategy is the cornerstone of hemodynamic management in ARDS. 1

  • Reduce driving pressure to <18 cmH2O by decreasing tidal volume if needed 1
  • Maintain PaCO2 <48 mmHg to avoid hypercapnic pulmonary vasoconstriction 1
  • Optimize PEEP to prevent lung derecruitment (which increases RV afterload) while avoiding overdistension 1
  • Avoid high mean airway pressures that worsen RV function 1

3. Hemodynamic Support Strategy

Norepinephrine is the drug of choice for hemodynamic support, NOT additional fluids. 1

  • Initiate or increase norepinephrine to restore mean arterial pressure and RV coronary perfusion 1
  • Avoid fluid boluses - excessive fluids are deleterious in RV failure and worsen cardiac output 1
  • Target MAP ≥65 mmHg to maintain RV perfusion 1

4. Consider Inhaled Pulmonary Vasodilators

For refractory hypoxemia with RV dysfunction, add inhaled nitric oxide (5-10 ppm) or inhaled prostacyclin (20-30 ng/kg/min). 1

  • Both agents reduce pulmonary vascular resistance without systemic hypotension 1
  • They improve ventilation/perfusion matching and may improve RV function 1
  • No mortality benefit proven, but reasonable for rescue therapy 1

5. Implement Prone Positioning if Not Already Done

Initiate prone positioning for >12 hours daily if PaO2/FiO2 <150 mmHg, as this significantly reduces mortality. 2

  • Prone positioning improves oxygenation and reduces ventilator-induced lung injury 2
  • Should be maintained for at least 12 hours per session 1

6. Rule Out Mechanical Ventilator Problems

Systematically check for ventilator circuit issues that cause acute deterioration. 3

  • Verify endotracheal tube position and patency
  • Check for pneumothorax (especially with high airway pressures)
  • Ensure ventilator circuit connections are secure
  • Assess for mucus plugging requiring suctioning 3

7. Reassess Infection Control

Given polymyxin B, meropenem, and levofloxacin coverage, consider resistant organisms or fungal superinfection. 4

  • Review culture results for multi-drug resistant organisms 4
  • Consider that some gram-negative organisms (like Pandoraea) may be meropenem-resistant but imipenem-sensitive 4
  • Evaluate for fungal pneumonia in prolonged ventilation 4

8. Consider ECMO if Refractory

If severe refractory hypoxemia persists despite neuromuscular blockade and prone ventilation (PaCO2 >60 mmHg), consider VV-ECMO at an experienced center. 1, 2

  • ECMO should only be implemented at centers with expertise 1
  • VV-ECMO facilitates lung-protective ventilation and allows lung recovery 3
  • Transpulmonary pressure-guided ventilation during ECMO increases successful weaning rates (71% vs 48%) 5

Critical Pitfalls to Avoid

  • Do not give fluid boluses - this worsens RV failure and increases risk of pulmonary edema 1
  • Do not use high-frequency oscillatory ventilation with high PEEP baseline - this worsens hemodynamics and increases RV failure risk 1, 2
  • Do not delay intubation optimization - sudden deterioration in severe ARDS can be rapidly fatal 1, 6
  • Do not ignore driving pressure - values ≥18 cmH2O independently predict RV failure 1

Monitoring Parameters

  • Continuous echocardiography assessment of RV function 1
  • Arterial blood gases every 1-2 hours during acute deterioration 7
  • Central venous pressure (though limited value due to transmitted pressure from high PEEP) 1
  • Mixed venous oxygen saturation if available 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Acute Respiratory Distress Syndrome with Prolonged International Normalized Ratio

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Respiratory Distress Management in CVICU

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Bronchopneumonia with ARDS and Bradycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.